Caprelsa

Medicinal product

(Invented) name

Caprelsa

Active substance (s)

Vandetanibas

Strength

300 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01EX04, vandetanib

Marketing authorisation holder

Sanofi B.V., Nyderlandai

Date of authorisation

2012-02-17

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Vandetanibas	300 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
51313	65207	1065207	lizdinė plokštelė	N30		Receptinis	EU/1/11/749/002	Tiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2012-02-17	Registruotas